Dr. Megan Roberts is the Assistant Director of User Services of the Immersion Lab at MIT.nano, a central facility for multidimensional and interactive data visualization, including augmented and virtual reality. She has over 10 years of experience designing devices, sensors, and materials for interface with the human body. Her research interests include medical technology and manufacturing. She previously worked at Medtronic designing implantable pacemakers. Dr. Roberts received her PhD in Mechanical Engineering from MIT.

Anna Osherov joined MIT's ONE Lab in the fall of 2013 as a postdoctoral associate and lab manager of the Eni-MIT Solar Frontiers Shared Experimental Facilities. Anna's research focuses on the correlation between morphology, microstructure, and physical properties of materials.

William D. Oliver is a Principal Investigator in the Engineering Quantum Systems Group (MIT campus) and the Quantum Information and Integrated Nanosystems Group (MIT Lincoln Laboratory).  He provides programmatic and technical leadership targeting the development of quantum and classical high-performance computing technologies. Will’s research interests include the materials growth, fabrication, design, and measurement of superconducting qubits, as well as the development of cryogenic packaging and control electronics involving cryogenic CMOS and single-flux quantum digital logic.

Vladimir Bulović is a Professor of Electrical Engineering at MIT holding the Fariborz Maseeh Chair in Emerging Technology. He directs the Organic and Nanostructured Electronics Laboratory, co-leads the MIT-Eni Solar Frontiers Center, leads the Tata GridEdge program, and is the Founding Director of MIT.nano, MIT's new 20,000 m2 nano-fabrication, nano-characterization, and prototyping facility that opened in the summer of 2018.

Derrick Katayama, Ph.D. is the Principal Scientist at Legacy BioDesign, LLC. Dr. Katayama received his Ph.D. in Pharmaceutical Sciences from the University of Colorado Health Sciences Center (UCHSC) with studies focused on understanding protein stability in both liquid and lyophilized forms. Dr. Katayama has worked in the biopharmaceutical industry for over 10 years, prior to joining Legacy BioDesign, LLC.

Stanley Y. Shaw, MD, PhD is the inaugural Associate Dean for Executive Education at Harvard Medical School. In this role, he designs and directs a growing portfolio of programs for companies and executive leaders from diverse sectors of health care, from small biotechs to Fortune 100 companies.